| http://www.w3.org/ns/prov#value | - In contrast, an antagonistic effect of CI-1033 and an anti-ErbB2 antibody, Herceptin, is disclosed. [0013] Thus, while there has been a great deal of research interest in the benzoquinone ansamycins, particularly geldanamycin and 17-AAG, there remains a need for effective therapeutic regimens to treat cancer or other diseases or conditions characterized by undesired cellular hyperproliferation usi
|
